Cargando…
Erythrodermic Psoriasis Exacerbated by Bupropion
Erythroderma is a rare, potentially life-threatening presentation of psoriasis that can be triggered by medication reactions. Bupropion is indicated for major depressive disorder (Wellbutrin®, GlaxoSmithKline, Research Triangle Park, NC), smoking cessation (Zyban®, GlaxoSmithKline, Research Triangle...
Autores principales: | Foss, Michael G, Nyckowski, Timothy, Steffes, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563139/ https://www.ncbi.nlm.nih.gov/pubmed/34745784 http://dx.doi.org/10.7759/cureus.18460 |
Ejemplares similares
-
Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
por: Beltran Monasterio, Eduardo P
Publicado: (2019) -
An Uncommon Presentation of Erythrodermic Psoriasis in a Patient Without a History of Psoriasis
por: Rendo, Matt, et al.
Publicado: (2019) -
Erythrodermic Psoriasis in a Man with Monoclonal B-cell Lymphocytosis
por: Chen, Stella X, et al.
Publicado: (2017) -
Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022) -
Distributive Shock in Erythrodermic Psoriasis Treated With Norepinephrine and Vasopressin: A Case Report
por: Karimi, Mehrdad, et al.
Publicado: (2023)